There are 4 papers on effector CD8+ T cells in aging research: 2 observational studies in people, 2 in animals. The newest story, Oct 5, 2026: “Nicotinamide riboside improves parasite control in mice”.
4 papers study it25 more mention it1 finding
1 new paper in 30 daysSee all 29 papers on effector CD8+ T cells
ANTI-CD49D antibody
downin mice1
ANTI-CD49D antibody decreases effector CD8+ T cells in mice (chronic TBI).
“aCD49d Ab reduces CD8+ T cells exhibiting higher effector status, leading to reduced clonal expansion in aged, but not young, mouse brains with chronic TBI.”
Animalschronic TBIbrain
bioRxiv : the preprint server for biologyPreprint
In mice infected with Trypanosoma cruzi, treatment with the NAD+ precursor improved CD8+ T-cell function and reduced parasite burden in blood and skeletal muscle.In mice infected with Trypanosoma cruzi, treatment with the NAD+ precursor improved CD8+ T-cell function and reduced parasite burden in blood and skeletal muscle.
Profiling blood and plaque samples from 12 patients and 21 controls linked elevated KRAS in senescent CD8+ T cells to premature coronary artery disease.Profiling blood and plaque samples from 12 patients and 21 controls linked elevated KRAS in senescent CD8+ T cells to premature coronary artery disease.